Literature DB >> 18847553

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.

F Xavier Bosch1, Ann N Burchell, Mark Schiffman, Anna R Giuliano, Silvia de Sanjose, Laia Bruni, Guillermo Tortolero-Luna, Susanne Kruger Kjaer, Nubia Muñoz.   

Abstract

Worldwide human papillomavirus (HPV) prevalence in women with normal cytology at any given point in time is approximately 10% indicating that HPV is one of the most common sexually transmitted infections. HPV-16 is consistently the most common type and HPV-18 the second with some minor regional differences. Furthermore, across the spectrum of cervical lesions, HPV-16 is consistently the most common HPV type contributing to 50-55% of invasive cervical cancer cases strongly suggesting that this viral type has a biological advantage for transmission, persistency and transformation. The same phenomenon is observed albeit at a lower level for HPV-18 and HPV-45. Sexual behavioral patterns across age groups and populations are central to the description of the HPV circulation and of the risk of infection. The concept of group sexual behavior (in addition to individual sexual behavior) is important in exploring HPV transmission and has implications for defining and monitoring HPV and cancer prevention strategies. In natural history studies, the pattern of HPV DNA prevalence by age groups is similar to the patterns of HPV incidence. Rates of exposure in young women are high and often include multiple types. There is a spontaneous and rapid decrease of the HPV DNA detection rates in the middle-age groups followed by a second rise in the post-menopausal years. This article reviews: 1) the evidence in relation to the burden of HPV infections in the world and the contributions of each HPV type to the spectrum of cervical cellular changes spanning from normal cytology to invasive cervical cancer; 2) the critical role of the patterns of sexual behavior in the populations; and 3) selected aspects of the technical and methodological complexity of natural history studies of HPV and cervical neoplasia.

Entities:  

Mesh:

Year:  2008        PMID: 18847553     DOI: 10.1016/j.vaccine.2008.05.064

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  239 in total

1.  Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types.

Authors:  Vanessa Zubach; Gerry Smart; Samuel Ratnam; Alberto Severini
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

Review 2.  Vaccines to prevent infections by oncoviruses.

Authors:  John T Schiller; Douglas R Lowy
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

3.  Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-20       Impact factor: 4.254

4.  Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis.

Authors:  Ann N Burchell; Allita Rodrigues; Veronika Moravan; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

Review 5.  The growing epidemic of sexually transmitted infections in adolescents: a neglected population.

Authors:  Chelsea L Shannon; Jeffrey D Klausner
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

Review 6.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

7.  Controlling cervical cancer.

Authors:  Maurizio Bonati; Silvio Garattini
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.

Authors:  Manola Comar; Michelle R Iannacone; Giorgia Casalicchio; Sandrine McKay-Chopin; Massimo Tommasino; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Assessing the need for and acceptability of a free-of-charge postpartum HPV vaccination program.

Authors:  Abbey B Berenson; Eneida Male; Toy G Lee; Alan Barrett; Kwabena O Sarpong; Richard E Rupp; Mahbubur Rahman
Journal:  Am J Obstet Gynecol       Date:  2013-11-23       Impact factor: 8.661

10.  A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.

Authors:  Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi
Journal:  J Infect Dis       Date:  2012-12-12       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.